Difference between revisions of "Template:Drugs for obstructive airway diseases"

From blackwiki
Jump to navigation Jump to search
(withdrawal of fenspiride)
 
(62 intermediate revisions by 29 users not shown)
Line 1: Line 1:
 
{{Navbox
 
{{Navbox
| name   = Drugs for obstructive airway diseases
+
| name = Drugs for obstructive airway diseases
| title = Drugs for [[obstructive airway disease]]s: [[asthma]]/[[Chronic obstructive pulmonary disease|COPD]] ([[ATC code R03|R03]])
+
| title = Drugs for [[obstructive airway disease]]s: [[asthma]]/[[Chronic obstructive pulmonary disease|COPD]] ([[ATC code R03|R03]])
| groupstyle = background:MistyRose;
+
| state = {{{state|autocollapse}}}
 +
| listclass = hlist
  
| group1 = [[adrenergic drug|Adrenergic]]s, [[inhalant]]s
+
| group1 = [[adrenergic drug|Adrenergic]]s, [[inhalant]]s
| list1  = {{Navbox subgroup
+
| list1  =
   | groupstyle = background-color: MistyRose
+
  {{Navbox|subgroup
 +
 
 +
   | group1 = [[Beta2-adrenergic_agonist#Short-acting_.CE.B22_agonists|Short-acting &beta;<sub>2</sub> agonists]]
 +
  | list1  =
 +
* [[Bitolterol]]
 +
* [[Carbuterol]]
 +
* [[Fenoterol]]
 +
* [[Isoetarine]]
 +
* [[Pirbuterol]]
 +
* [[Procaterol]]
 +
* [[Reproterol]]
 +
* [[Rimiterol]]
 +
* [[Salbutamol|Salbutamol (albuterol)]]<sup>#</sup>/[[Levosalbutamol|Levosalbutamol (levalbuterol)]]
 +
* [[Terbutaline]]
 +
* [[Tulobuterol]]
  
   | group1 = [[beta2-adrenergic agonist|Short acting &beta;<sub>2</sub>-agonists]]
+
   | group2 = [[Long-acting beta-adrenoceptor agonist|Long-acting &beta;<sub>2</sub> agonists]]
   |  list1 = [[Salbutamol]]<sup>#</sup>/[[Levosalbutamol]] [[Fenoterol]] [[Terbutaline]] [[Pirbuterol]] • [[Procaterol]] • [[Bitolterol]] • [[Rimiterol]] •  [[Carbuterol]] • [[Tulobuterol]] • [[Reproterol]]
+
   | list2 =  
 +
* [[Bambuterol]]
 +
* [[Clenbuterol]]
 +
* [[Formoterol]]/[[Arformoterol]]
 +
* [[Salmeterol]]
 +
* [[Salmefamol]]
  
   | group2 = [[Long acting beta-adrenoceptor agonist|Long acting &beta;<sub>2</sub>-agonists]] (LABA)
+
   | group3 = [[Long-acting_beta-adrenoceptor_agonist#Ultra-LABAs|Ultra-long-acting &beta;<sub>2</sub> agonists]]
   | list2 = [[Arformoterol]] [[Bambuterol]] [[Clenbuterol]] [[Formoterol]] [[Salmeterol]] ''Ultra LABA:'' [[Indacaterol]]
+
   | list3 =  
 +
* [[Abediterol]]
 +
* [[Carmoterol]]
 +
* [[Indacaterol]]
 +
* [[Olodaterol]]
 +
* [[Vilanterol]]
  
   | group3 = other
+
   | group4 = Other
   |  list3 = [[Epinephrine]]<sup>#</sup> [[Hexoprenaline]] [[Isoprenaline|Isoprenaline (Isoproterenol)]] [[Orciprenaline|Orciprenaline (Metaproterenol)]]
+
   | list4 =  
 
+
* [[Epinephrine]]<sup>#</sup>
 
+
* [[Hexoprenaline]]
}}
+
* [[Isoprenaline|Isoprenaline (isoproterenol)]]
 +
* [[Orciprenaline|Orciprenaline (metaproterenol)]]
 +
  }}
  
 
| group2 = [[Glucocorticoid]]s
 
| group2 = [[Glucocorticoid]]s
| list2  = [[beclometasone dipropionate|Beclometasone]]<sup>#</sup> [[Budesonide]] [[Ciclesonide]] [[Fluticasone]] [[Mometasone furoate|Mometasone]] [[Flunisolide]] [[Betamethasone]] [[Triamcinolone]]
+
| list2  =  
 +
* [[Beclometasone dipropionate|Beclometasone]]<sup>#</sup>
 +
* [[Betamethasone]]<sup>#</sup>
 +
* [[Budesonide]]
 +
* [[Ciclesonide]]
 +
* [[Flunisolide]]
 +
* [[Fluticasone propionate]]
 +
* [[Mometasone furoate|Mometasone]]
 +
* [[Triamcinolone]]
  
| group3 =[[Anticholinergic]]s/<BR>[[muscarinic antagonist]]
+
| group3 = [[Anticholinergic]]s/<br>[[muscarinic antagonist]]
| list3  =[[Ipratropium]]<sup>#</sup> [[Tiotropium]]
+
| list3  =  
 +
* [[Aclidinium bromide]]
 +
* [[Glycopyrronium bromide]]
 +
* [[Ipratropium bromide]]<sup>#</sup>
 +
* [[Oxitropium bromide]]
 +
* [[Tiotropium bromide]]
 +
* [[Umeclidinium bromide]]
  
 
| group4 = [[Mast cell stabilizer]]s
 
| group4 = [[Mast cell stabilizer]]s
| list4  = [[Cromoglicate]] [[Nedocromil]]
+
| list4  =  
 +
* [[Cromoglicate]]
 +
* [[Nedocromil]]
  
 
| group5 = [[Xanthine]]s
 
| group5 = [[Xanthine]]s
| list5  = [[Doxofylline]] [[Enprofylline]] [[Theobromine]] [[Theophylline]]/[[Aminophylline]]
+
| list5  =  
 +
* [[Acefylline]]
 +
* [[Ambuphylline]]
 +
* [[Bamifylline]]
 +
* [[Doxofylline]]
 +
* [[Enprofylline]]
 +
* [[Etamiphylline]]
 +
* [[Proxyphylline]]
 +
* [[Theophylline]]/[[Aminophylline]]/[[Choline theophyllinate]]
  
| group6 = [[Eicosanoid]] inhibition
+
| group6 = [[Eicosanoid]] inhibition
| list6  = {{Navbox subgroup
+
| list6  =
| groupstyle = background-color: MistyRose
+
  {{Navbox|subgroup
 +
 
 +
  | group1 = [[Leukotriene antagonist]]s
 +
  | list1  =  
 +
* [[Montelukast]]
 +
* [[Pranlukast]]
 +
* [[Zafirlukast]]
  
| group1 = [[Leukotriene antagonist]]s
+
  | group2 = [[Arachidonate 5-lipoxygenase inhibitor]]s
| list1 = [[Montelukast]] • [[Pranlukast]] • [[Zafirlukast]]
+
  | list2 =  
 +
* [[Zileuton]]
  
| group7 = [[Lipoxygenase inhibitor]]
+
  | group3 = [[Thromboxane receptor antagonist]]s
| list7 = [[Zileuton]]
+
  | list3 =  
 +
* [[Ramatroban]]
 +
* [[Seratrodast]]
  
| group8 = [[Thromboxane receptor antagonist]]s
+
  | group4 = Non-xanthine [[PDE4 inhibitor]]s
| list8 = [[Ramatroban]] [[Seratrodast]]
+
  | list4 =  
 +
* [[Ibudilast]]
 +
* [[Roflumilast]]
 +
  }}
  
 +
| group7 = Others/unknown
 +
| list7  =
 +
* [[Amlexanox]]
 +
* [[Eprozinol]]
 +
* [[Fenspiride]]<sup>‡</sup>
 +
* [[Omalizumab]]
  
 +
| group9 = Combination products
 +
| list9  =
 +
* [[Aclidinium bromide/formoterol]]
 +
* [[Beclometasone/formoterol]]
 +
* [[Beclometasone/formoterol/glycopyrronium bromide]]
 +
* [[Budesonide/formoterol]]
 +
* [[Budesonide/glycopyrronium bromide/formoterol]]
 +
* [[Fluticasone furoate/umeclidinium bromide/vilanterol]]
 +
* [[Fluticasone furoate/vilanterol]]
 +
* [[Fluticasone propionate/salmeterol]]
 +
* [[Glycopyrronium bromide/formoterol]]
 +
* [[Indacaterol/glycopyrronium bromide]]
 +
* [[Indacaterol/glycopyrronium bromide/mometasone]]
 +
* [[Indacaterol/mometasone]]
 +
* [[Ipratropium bromide/salbutamol]]
 +
* [[Mometasone/formoterol]]
 +
* [[Umeclidinium bromide/vilanterol]]
  
 +
| belowstyle = background: transparent; padding: 0px;
 +
 +
| below = {{PharmNavFootnote}}
  
 
}}
 
}}
| group9 = Combination products
+
<noinclude>
| list9 = [[Budesonide/formoterol]] • [[Fluticasone/salmeterol]] • [[Ipratropium/salbutamol]]
+
{{collapsible option}}
 
 
| list10 = {{PharmNavFootnote}}
 
| belowstyle = background: transparent; padding: 0px;
 
| below = {{Respiratory system navs}}
 
  
}}<noinclude>
+
[[Category:Antiasthmatic drugs]]
 +
[[Category:Drug templates by ATC]]
  
[[Category:Drug_templates by ATC|{{PAGENAME}}]]
 
[[hu:Sablon:AsztmaCOPD]]
 
 
</noinclude>
 
</noinclude>

Latest revision as of 17:20, 26 October 2020

Initial visibility: currently defaults to autocollapse

To set this template's initial visibility, the |state= parameter may be used:

  • |state=collapsed: {{Drugs for obstructive airway diseases|state=collapsed}} to show the template collapsed, i.e., hidden apart from its title bar
  • |state=expanded: {{Drugs for obstructive airway diseases|state=expanded}} to show the template expanded, i.e., fully visible
  • |state=autocollapse: {{Drugs for obstructive airway diseases|state=autocollapse}}
    • shows the template collapsed to the title bar if there is a {{navbar}}, a {{sidebar}}, or some other table on the page with the collapsible attribute
    • shows the template in its expanded state if there are no other collapsible items on the page

If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.